Impel NeuroPharma

Read more
Adrian Adams's photo - Chairman & CEO of Impel NeuroPharma

Chairman & CEO

Adrian Adams

CEO Approval Rating

90/100

Founded:

2008

Status:

PublicIndependent CompanyNASDAQIMPL

IMPEL NEUROPHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Adrian Adams

Chairman & CEO

- -
59
$264.4M
$ < 1M
View Profile
1

Peter K Miller

CEO

90/100
102
$528.9M
$54M
View Profile
2

Vlad Coric

CEO

92/100
63
$748.3M
$106.3M
View Profile
3

David A. Ricks

Chairman & CEO

65/100
38,680
- -
$25.5B
View Profile
4

CEO

- -
16,900
$31.1M
$16B
View Profile
5

Robert W. Azelby

President & CEO

82/100
202
$610M
$6.5M
View Profile
6

Dame Emma Walmsley

CEO

74/100
94,066
- -
$45.2B
View Profile
7

Jeffrey A. Meckler

CEO

73/100
36
$45M
$ < 1M
View Profile
8

John Kollins

President & CEO

89/100
18
$156.6M
View Profile
9

Craig C. Chambliss

President & CEO

90/100
130
$221.8M
$3M
View Profile
10

Michael Higgins

Interim-CEO

82/100
123
$267.1M
$159.6M
View Profile

Missing a competitor? Contribute!

Impel NeuroPharma Quarterly and Annual Revenue

Coming soon for Impel NeuroPharma!

Annual Revenue

Impel NeuroPharma Acquisitions

No recent acquisitions found related to Impel NeuroPharma

Impel NeuroPharma Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Post-IPO Debt
Jul 2021
$50M

Oxford Finance LLC

IPO
Apr 2021
$98.1M
-
Debt
Mar 2021
$7.5M
Series D
Dec 2018
$67.5M
Series C
Nov 2016
$22.3M

Impel NeuroPharma Investments

No recent investments found related to Impel NeuroPharma

Impel NeuroPharma News

Impel NeuroPharma Press Releases

Social Media

Impel NeuroPharma Headquarters

201 Elliott Avenue West Suite 260

Seattle, Washington98119

206-568-1466

Driving Directions »

Trending Companies

Impel NeuroPharma Summary

ABOUT

Overview

Impel NeuroPharma is a Washington-based biopharmaceutical company that develops and commercializes nasal drug delivery therapeutics for the treatment of CNS disorders. Impel NeuroPharma was founded in 2008. Impel NeuroPharma's headquarters is located ...

CEO

Impel NeuroPharma's Chairman & CEO, Adrian Adams, currently has an approval rating of 90%. Impel NeuroPharma's primary competitors are OptiNose, Biohaven & Eli Lilly.

Frequently Asked Questions about Impel NeuroPharma

  1. When was Impel NeuroPharma founded?

    Impel NeuroPharma was founded in 2008
  2. Who is Impel NeuroPharma's CEO?

    Impel NeuroPharma's CEO is Adrian Adams
  3. How much revenue does Impel NeuroPharma generate?

    Impel NeuroPharma generates $ < 1M in revenue
  4. How much funding does Impel NeuroPharma have?

    Impel NeuroPharma has historically raised $264.4M in funding
  1. Where is Impel NeuroPharma's headquarters?

    Impel NeuroPharma's headquarters is in Seattle Washington, USA
  2. How many employees does Impel NeuroPharma have?

    Impel NeuroPharma has 59 employees
  3. What sector does Impel NeuroPharma operate in?

    Impel NeuroPharma is in Pharmaceuticals
  4. Who are Impel NeuroPharma's competitors?

    Impel NeuroPharma's top competitors are OptiNose, Biohaven, Eli Lilly